Introduction of a new Vaccine into National Immunisation Programmes in Africa: The role of Capacity Building
BMJ Global Health 2017;2(Suppl 2):A53
High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa
Vaccine 2016; 34(33): 3835-3839.
Evaluation of a Training DVD on Pneumococcal Conjugate Vaccine for Kenyan EPI Health Care Workers
Education for Health 2016; 29: 35-41.
Enhancing capacity of professionals and academics for vaccines and immunization in Africa: The 3rd Regional Vaccinology Course for Francophone Countries, Mbour, Senegal, 12th – 19th September 2015
Annals of Vaccines and Immunization 2015; 2(1): 1011.
HPV vaccines for the prevention of cervical cancer and genital warts: an update
Vaccine 2014; 32: 1595-1601.
Introducing New Vaccines into the South African National Immunisation Programme - a Case Study
Elsevier, Vaccine Journal, Volume 30, Supplement 3, 7 September 2012.
The South African Immunisation Programme was the first in Africa to introduce hepatitis B and Haemophilus Influenzae type b vaccines respectively in 1995 and 1999. A decade later three new vaccines (against rotavirus and pneumococcal infections, and IPV in a combined vaccine) were introduced simultaneously in 2009. All these initiatives were realised with own financial resources (no donor-support for a middle-income country). After implementation of the respective vaccines, an “Experience Exchange Meeting on the Introduction of New Vaccines” was held in Pretoria, South Africa (28-30 July 2010) with the participation of eleven African countries. During this meeting, the idea matured that the unique South African experience should be put to record; in that way all countries of the world could benefit from lessons learned and challenges related to this major public health intervention.
This lead to the publication of a supplement with 14 chapters in “Vaccine” Journal in 2012: “Introducing New Vaccines into the South African National Immunisation Programme – a Case Study”. The supplement was developed as a collaborative effort between the South African Vaccination and Immunisation Centre - SAVIC (at the University of Limpopo, South Africa) and the Network for Education and Support in Immunisation – NESI (at the University of Antwerp, Belgium).
Vaccines and Their Use in The Adolescent and Adult Population
3rd Bandung Infectious Diseases Symposia - International Research Seminar in Infection Disease 17-19 November 2011; 36.
Evaluation of mid-level management training in immunisation in the African Region
East African Journal of Public Health March 2010; 7(1):39-45.
HPV vaccines and prevention of cervical cancer
Belgian Journal of Medical Oncology 2009; 3(6):274-280.
Vaccination in the line of fire
Southern African Journal of Epidemiology and Infection 2008; 23:53-57.